We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$618B
AUM Growth
-$47.4B
Cap. Flow
-$19.5B
Cap. Flow %
-3.16%
Top 10 Hldgs %
21.78%
Holding
14,860
New
2,347
Increased
5,138
Reduced
5,286
Closed
2,003

Sector Composition

Rank Sector Weight
1 Technology 4.49%
2 Healthcare 2.99%
3 Financials 2.85%
4 Industrials 2.56%
5 Consumer Discretionary 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNNT
13901
Pennant Park Investment Corp
PNNT
$220M
-73,389
Closed -$390K
PNQI icon
13902
Invesco NASDAQ Internet ETF
PNQI
$527M
-4,443
Closed -$240K
PODC icon
13903
PodcastOne
PODC
$105M
-45,972
Closed -$114K
POLA icon
13904
Polar Power
POLA
$5.42M
-16,661
Closed -$27.8K
PPBT
13905
CALL
Purple Biotech
PPBT
$1.29M
-1,250
Closed -$8.22K
PPBT
13906
Purple Biotech
PPBT
$1.29M
-4,274
Closed -$28.1K
PPBT
13907
PUT
Purple Biotech
PPBT
$1.29M
-4,750
Closed -$31.2K
PPIH
13908
PUT
Perma-Pipe International
PPIH
$189M
-28,500
Closed -$865K
PPH icon
13909
CALL
VanEck Pharmaceutical ETF
PPH
$985M
-3,200
Closed -$330K
PPH icon
13910
PUT
VanEck Pharmaceutical ETF
PPH
$985M
-5,600
Closed -$578K
PPSI
13911
Pioneer Power Solutions
PPSI
$30.8M
-23,181
Closed -$93.7K
PPSI
13912
PUT
Pioneer Power Solutions
PPSI
$30.8M
-12,600
Closed -$59.6K
PRAX icon
13913
Praxis Precision Medicines
PRAX
$8.11B
-34,917
Closed -$10.8M
PRCT icon
13914
Procept Biorobotics
PRCT
$1.02B
-91,061
Closed -$2.57M
PREF icon
13915
Principal Spectrum Preferred Securities Active ETF
PREF
$1.77B
-19,869
Closed -$379K
PRFZ icon
13916
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.74B
-18,148
Closed -$833K
PRG icon
13917
CALL
PROG Holdings
PRG
$1.71B
-8,700
Closed -$257K
PRLB icon
13918
PUT
Protolabs
PRLB
$1.7B
-6,800
Closed -$344K
PRN icon
13919
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$382M
-1,476
Closed -$258K
PROK icon
13920
ProKidney
PROK
$316M
-371,797
Closed -$789K
PROK icon
13921
PUT
ProKidney
PROK
$316M
-15,500
Closed -$34.7K
PRQR icon
13922
CALL
ProQR Therapeutics
PRQR
$244M
-34,200
Closed -$69.1K
PRT
13923
PermRock Royalty Trust Unit
PRT
$25.8M
-37,958
Closed -$106K
PSCH icon
13924
Invesco S&P SmallCap Health Care ETF
PSCH
$162M
-10,110
Closed -$445K
PSCI icon
13925
Invesco S&P SmallCap Industrials ETF
PSCI
$180M
-5,888
Closed -$884K

Similar funds

Citadel Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Citadel Advisors withdrew a net $19.5B in Q1 2026, closing 2,003 positions and reducing 5,286 holdings. Its most notable exit was CyberArk, an estimated $305M position sold in full.

By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 4.9% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citadel Advisors opened a new position in iShares 7-10 Year Treasury Bond ETF worth $327M.

  • Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
  • Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
  • Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
  • Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
  • Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
  • Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
  • Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.